Scientific article 22. JUL 2013
Individualised therapy is more cost-effective than dose intensification in patients with Crohn's disease who lose response to anti-TNF treatment
Authors:
- Casper Steenholdt
- Jørn Brynskov
- Ole Østergaard Thomsen
- Lars Kristian Munck
- Jan Fallingborg
- Lisbet Ambrosius Christensen
- Gitte Pedersen
- Jens Kjeldsen
- Bent Ascanius Jacobsen
- Anne Sophie Oxholm
- Jakob Kjellberg
- Klaus Bendtzen
- Mark Andrew Ainswort
Authors
- Casper SteenholdtJørn BrynskovOle Østergaard ThomsenLars Kristian MunckJan FallingborgLisbet Ambrosius ChristensenGitte PedersenJens KjeldsenBent Ascanius JacobsenAnne Sophie OxholmJakob KjellbergKlaus BendtzenMark Andrew Ainswort
About this publication
Published in
GUT
